Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
New data keeps AbbVie’s star pipeline therapies on track
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
Latest news
-
Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress
Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress. ... Biohaven has unveiled early results for its candidate BHV-0223 which it believes could be prescribed to people suffering ‘social anxiety
-
Love Island ads fuel body image problems, warn health leaders
We know young women are the fastest growing group suffering from mental health issues, that anxiety problems are more common among women aged 16-24 and that a quarter of women
-
NHS bracing for 'no deal’ Brexit impact, including medicines
The reality is that medicines, medical supplies and devices are all part of a highly interdependent system – it would be wrong to cause unnecessary anxiety or alarm among patients, but we
-
Alexion adds to pipeline rebuild with $855m Wilson buy
Alexion put to rest some of the anxiety about its ability to diversify beyond paroxysmal nocturnal haemoglobinuria (PNH) treatment Soliris (eculizumab) when it reported phase III data for follow-up ALXN1210,
-
NICE backs trial of online and mobile depression programme
The briefing is the first fruit of a programme NICE launched last year to assess the use of digital therapies, such as computer programmes or applications, to treat anxiety and depression.
More from news
Approximately 1 fully matching, plus 143 partially matching documents found.
Latest Intelligence
-
The Patient Safety Challenge
There were anxieties about how reporting could affect their reputations and career prospects.
-
Finding the patient voice
This data provided the big picture about what motivates people to join clinical trials, their anxieties and their experiences. ... we should communicate with them, depending on their needs and anxieties.
-
Grünenthal's relentless pursuit of relief
The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression
-
Mining for results
And being on AWS certainly does help in that regard. it takes a good amount of their anxiety away,” he explains.
-
An effective commercial model for cancer care
as anxiety, energy and stress. ... Even when treatment is completed and no cancer remains, serious residual effects such as depression, anxiety and post-traumatic stress disorder impair patients' abilities to perform activities of daily living, limiting
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Artificial Intelligence in Healthcare
Stoking the fires of both patients’ and healthcare professionals’ (HCP) anxiety regarding the implementation of such a monumental system change are the hordes of drug makers who are beating on the
-
Neurofeedback Systems Market to Witness an Outstanding Growth During 2017 – 2027
Attention Deficit Hyperactivity Disorder (ADHD). Anxiety. Depression. Epilepsy. Insomnia. Drug Addiction.
-
World Diabetes Day: Interaction and impact of diabetes on mental health
and Masharani, U., 2008. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes.
-
ADHD and Employment
they generally persist through to adulthood, leading to on average worse educational, occupational, economic, social and relationship outcomes,[3] with higher rates of comorbidities such as mood, anxiety and sleep
-
Apple Watch Series 4: A life-saving tool or just making us more health obsessed?
I was once told that health anxiety (often known as hypochondriasis) is one of the most common types of anxiety. ... by its wearers in a negative fashion - instilling fear and anxiety in many.
More from PMHub
Approximately 0 fully matching, plus 25 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Competitive Salary
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Account Director
-
£48, 000 - £60, 000
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
New Business Director - PR
-
Competitive Salary and benefits
-
Medical Writers
-
Competitive Salary and Benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Account Director
-
Excellent benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Medical/ Scientific Director
-
Salary TBC
Subscribe to our email news alerts
- Worldwide Clear Aligner Market to grow at a CAGR of 16.15% By 2023
- Worldwide Prenatal and New-born Genetic Testing Market Set to Register 11.9% CAGR During 2018-2024
- Medical Biomimetics Market soaring at 5.5% CAGR to Hit USD 34.4 Billion By 2024
- Medical Marijuana Market to Soar at 36% CAGR to 2024
- Worldwide Medical Ultrasound Imaging Equipment Market to Witness Robust Expansion Throughout the Forecast Period 2018 – 2023
- Worldwide Home Infusion Therapy Market Soaring at 9% CAGR to Hit USD 28 Billion by 2024
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
